Paragraph 33
Where and in so far as the licence relates to special medicinal products, the licence holder may only import such products from F1, in the case of an import into Great Britain, an approved country for import and in the case of an import into Northern Ireland, an EEA State—
(a)
in response to an order which satisfies the requirements of regulation 167, and
(b)
where the conditions set out in paragraphs 34 to 41 are complied with.
Annotations
Textual amendments
- F1
Words in Sch. 4 para. 33 substituted (31.12.2020) by S.I. 2019/775, reg. 20(6) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 14(e))